Work

Abstract 947: The FLT3 inhibitor AC220 (quizartinib) inhibits drug transport by ABCG2 at pharmacologically relevant concentrations and sensitizes cells to ABCG2 substrate chemotherapy drugs.

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2013-947

Authors: Jasjeet Bhullar, Karthika Natarajan, Suneet Shukla, Suresh V. Ambudkar, Maria R. Baer

Institutions: University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, National Cancer Institute

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2038736203

Cites:

Cited by:

Related to: 10